Where does Catalent Pharma Solutions, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Catalent Pharma Solutions, LLC ranks #45,497 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Catalent Pharma Solutions, LLC hold?

Catalent Pharma Solutions, LLC holds 5 US utility patents granted between 2017 and 2024, spanning 7 technology areas.

What is Catalent Pharma Solutions, LLC's Innovation Score?

Catalent Pharma Solutions, LLC has an Innovation Score of 41.7 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Catalent Pharma Solutions, LLC focus on?

Catalent Pharma Solutions, LLC's top technology area is C07K (Peptides) with 5 patents, ranking #1,584 of 3,615 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Catalent Pharma Solutions, LLC's patent grant rate increasing or decreasing?

Catalent Pharma Solutions, LLC's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Catalent Pharma Solutions, LLC's patents?

Catalent Pharma Solutions, LLC's patents average 10.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Catalent Pharma Solutions, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Catalent Pharma Solutions, LLC

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Catalent ranks #45,497 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#45,497
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.7/100): 10.2
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45497 · US Corporation #45,497 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,497/49,997
PHOTO-FINISH CARS COM
CPC-NARROW C07K · 7 areas
INNOV-PAR 41.7/100
CLAIMS-PAR 10.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CARS.COM, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Catalent’s 41.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (15%) Velocity 20.0 pts (48%) Breadth 9.4 pts (23%) Claim depth 6.1 pts (15%)

Qualcomm Incorporated · highest

85
Catalent Pharma… · this assignee

42
3D Lighting… · lowest

7

What this shows Catalent's Innovation Score is 41.7/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Catalent?

Each dot is one of Catalent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Catalent’s own 10.2 claims/patent is at or below the 12.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Catalent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Catalent's grants concentrate

Catalent Pharma Solutions, LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2017. By volume, Catalent sits between CARS.COM, LLC and Cavity Sliders Limited.

Catalent's three-year grant acceleration

Catalent Pharma Solutions, LLC shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

CARS COM

5
CAS

5
Case Western Univ…

5
Castle Island IP…

5
Catalyst Orthopae…

5
Caterva

5
Cava Healthcare

5
Cavity Sliders

5
Catalent Pharma S… ◀

5

What this shows Catalent holds 5 patents at rank #45,456, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Catalent

By rank, the assignees closest to #45,456 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Catalent's primary technology class.

Catalent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Catalent Pharma Solutions, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2018	1	20.0%
2022	1	20.0%
2024	2	40.0%

Which technologies does Catalent Pharma Solutions, LLC patent most?

C07K - Peptides 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Catalent Pharma Solutions, LLC's patent record in context - here's where to go next.

Catalent Pharma Solutions, LLC's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #45,497 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Catalent Pharma Solutions, LLC against CARS.COM, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.